Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
PaperCitations, authors & open-access status
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 472 citations, 2020 year and closed oa status.
472
Citations
2020
Year
closed
OA Status